While dealing with a suit filed by Dabur India against commercial advertisements of Patanjali Ayurved allegedly disparaging ...

The Delhi High Court recently held that advertisements relating to regulated drugs such as Chyawanprash must adhere to ...

The market size of adhatoda vasica extract has grown strongly in recent years. It will increase from $1.18 billion in 2024 to $1.29 billion in 2025 at a compound annual growth rate CAGR of 9.3%. The ...

The Delhi High Court (HC) has restrained Patanjali Ayurved from publishing or broadcasting advertisements that allegedly ...

Ayurveda News: Patanjali Ayurveda asserts that its products have carved a special place in Indian homes. In today’s times, as ...

Dabur had in December 2024 moved Delhi High Court against Patanjali for defaming the company by claiming that manufacturers ...

Scientists at Patanjali have made significant advancements in the treatment of Osteoarthritis or Arthritis, a condition ...

Delhi High Court's decision to restrain Patanjali's advertisement comes in response to a petition filed by Dabur India ...

The Delhi High Court has issued an interim injunction against Patanjali, owned by Ramdev, preventing them from running disparaging advertisements against Dabur's Chyawanprash. Dabur alleged that ...

The interim order was passed by Justice Mini Pushkarna in response to a lawsuit filed by Dabur, which accused Patanjali of misleading claims aimed at undermining its long-established product. While ...

The Delhi High Court has prohibited Patanjali from airing allegedly defamatory ads against Dabur Chyawanprash. An interim ...

Delhi High Court restrains Patanjali Ayurved from disparaging Dabur Chyawanprash in ads, granting interim injunction.